A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
01/2005
01/04/2005	CA2332406C Treatment of neuromuscular disorders and conditions with different botulinum serotype
01/04/2005	CA2288341C Erythropoietin in the treatment of domestic and livestock animals for anemia
01/04/2005	CA2285023C High avidity polyvalent and polyspecific reagents
01/04/2005	CA2144950C Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide
01/04/2005	CA2139725C Endoparasiticidal compositions
12/2004
12/30/2004	US20040268440 Transgenic plants expressing cobalamin binding proteins
12/30/2004	US20040268426 P2Y4 receptor transgenic and knockout non-human mammals
12/30/2004	US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms
12/30/2004	US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening
12/30/2004	US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride
12/30/2004	US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/30/2004	US20040267000 Atherosclerosis susceptibility gene locus 1(athsq1) and atherosclerosis susceptibility gene locus 2 (athsq2)
12/30/2004	US20040266995 Fibrinogenolytic proteases with thrombolytic and antihypertensive activities from Taiwan habu: medical application and novel process of expression and production
12/30/2004	US20040266994 Type-1 ribosome-inactivating protein
12/30/2004	US20040266991 Biologically active peptides and their use for repairing injured nerves
12/30/2004	US20040266990 Cd109 nucleic acid molecules polypeptides and methods of use
12/30/2004	US20040266989 Methods and compositions for the treatment of gastrointestinal disorders
12/30/2004	US20040266988 Macrocyclic peptidomimetic for use in treatment of multiple sclerosis and autoimmune disorders
12/30/2004	US20040266987 Attenuated flavivrus strains containing a mutated m-ectodomain and their applications
12/30/2004	US20040266805 Inflammation modulatory compound
12/30/2004	US20040266766 Selective urokinase inhibitors
12/30/2004	US20040266736 Particularly preferred inhibitors are low molecular weight substances unable to cross the blood/brain barrier, and act systemically and not centrally
12/30/2004	US20040266731 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
12/30/2004	US20040266721 Methods and compositions for inhibiting the function of polynucleotide sequences
12/30/2004	US20040266720 Splice-region antisense composition and method
12/30/2004	US20040266718 Inhibition of specific histone deacetylase isoforms
12/30/2004	US20040266717 Administering polynucleotide capable of modulating an electrical property in a standard cardiac electrophysiological assay; expressing the polynucleotide in the mammal to prevent or treat the cardiac arrhythmia
12/30/2004	US20040266716 Administering polynucleotide capable of modulating an electrical property in a standard cardiac electrophysiological assay; expressing the polynucleotide in the mammal to prevent or treat the cardiac arrhythmia
12/30/2004	US20040266715 Neurite regeneration
12/30/2004	US20040266705 Hybrid nucleic acid; prevent gene expression; therapy for atherosclerosis, cardiovascular and metabolism disorders
12/30/2004	US20040266702 Topical treatment or prevention of ocular infections
12/30/2004	US20040266698 Pyrane derivatives as both ace-and nep-inhibitors
12/30/2004	US20040266697 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone
12/30/2004	US20040266696 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones
12/30/2004	US20040266695 Novel LHRH antagonists having improved solubility properties
12/30/2004	US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor
12/30/2004	US20040266693 Antibody for diagnosising immunology disorders
12/30/2004	US20040266692 Gastrointestinal disorders
12/30/2004	US20040266691 for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; promoting axonal regeneration, inhibiting the effects of scar tissue formation
12/30/2004	US20040266690 Formation of novel erythropoietin conjugates using transglutaminase
12/30/2004	US20040266689 Use of calmodulin to promote bone regeneration
12/30/2004	US20040266688 Methods for modulating endometrium
12/30/2004	US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents
12/30/2004	US20040266686 Administering endothelial growth factor antagonist; wound healing agents
12/30/2004	US20040266685 Use of relaxin to treat diseases related to vasoconstriction
12/30/2004	US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents
12/30/2004	US20040266683 Prevention and treatment of cardiac arrhythmias
12/30/2004	US20040266682 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits
12/30/2004	US20040266681 Use of colostrinin,constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
12/30/2004	US20040266680 FGF-8 methods of use
12/30/2004	US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide
12/30/2004	US20040266678 Methods and compositions for treating polycystic ovary syndrome
12/30/2004	US20040266677 Method of diagnosing and treating lens illnesses using human HSF4 gene and coded product thereof
12/30/2004	US20040266676 Preventives/remedies for proliferative organ diseases chronic arthritic diseases. hypertrophic scar or keloid
12/30/2004	US20040266675 Transgenic aniomal nmodels; screening; administering peptide
12/30/2004	US20040266674 For diagnosis, therapy, prevention of cell proliferation, autoimmune disease, antiinflammatory agents, cardiovascular disorders, central nervous system disorders; isolated nucleic acids; genetic engineeringo
12/30/2004	US20040266673 Cardiovascular disorders; congestive heart failure
12/30/2004	US20040266672 Antiinflammatory agents; anticoagulants; viricides
12/30/2004	US20040266671 Orally administered peptides synergize statin activity
12/30/2004	US20040266670 Reduce blood glucose concentration
12/30/2004	US20040266669 Cyclosporin derivatives for the treatment of immune disorders
12/30/2004	US20040266668 Prevent reproduction of hepatitis virus
12/30/2004	US20040266667 Streptogramin derivatives, preparation method and compositions containing same
12/30/2004	US20040266666 Cross-linked glycopeptide-cephalosporin antibiotics
12/30/2004	US20040266665 Therapy for thyroid disease; anticancer agents; metabolitic and reproductive diseases
12/30/2004	US20040266664 Enzyme inhibition
12/30/2004	US20040266663 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and bruch's membrane (BM)
12/30/2004	US20040266660 Hdl for the treatment of stroke and other ischemic conditions
12/30/2004	US20040266006 Adenoviral vectors having a protein IX deletion
12/30/2004	US20040265995 Using frizzled-related proteins (FRP) to induce stem cell proliferation for use in treatment of blood, cell proliferative and autoimmune diseases
12/30/2004	US20040265982 Peptide or mimetic which enhances cholesterol ester hydrolase activity for use in identifying modulators for treatment and prevention of cardiovascular disorders
12/30/2004	US20040265981 A cDna clone; culturing liver cell in coditioning media
12/30/2004	US20040265976 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography
12/30/2004	US20040265975 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/30/2004	US20040265974 Human chemokine polypeptides
12/30/2004	US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases
12/30/2004	US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders
12/30/2004	US20040265970 Nucleotide sequences comprising sequences coding alternatively spliced neuregulin for use in treating and diagnosing cell proliferative disorders
12/30/2004	US20040265968 Tissue plasminogen activator-like protease
12/30/2004	US20040265967 14790, a novel protein kinase molecule and uses therefor
12/30/2004	US20040265966 Secreted and transmebrane polypeptides and nucleic acids encoding the same
12/30/2004	US20040265963 Inhibitory peptide for use in treatment and prevention of nervous system, connective tissue, autoimmune, inflammatory and cell proliferative disorders
12/30/2004	US20040265958 that hydrolyzes fatty amides such as cis-9,10-octadecenoamide to neutralize the soporific activity of the fatty amides; enzyme inhibitors for use in treating sleep disorders
12/30/2004	US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression
12/30/2004	US20040265951 Biomimetic gelation system for use as surgical sealant and medical adhesive
12/30/2004	US20040265935 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
12/30/2004	US20040265932 Detecting mRNA which translates into mammaglobin and mucin-like proteins, then detecting cDNA; isolated from Bacillus substilis; solid phase synthesis
12/30/2004	US20040265931 Ubiquitin hydrolase/deubiquitinase (HAUSP-Mdm2) complexes; p53 binding proteins; for diagnosis/treatment of neoplasia/carcinoma; drug screening; kits
12/30/2004	US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells
12/30/2004	US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/30/2004	US20040265894 G-protein chemokine receptor; use in drug screening and diagnosis of conditions related to the underexpression of the G-protein coupled receptor polypeptides by detecting a mutation
12/30/2004	US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening
12/30/2004	US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis
12/30/2004	US20040265888 Binary encoded sequence tags
12/30/2004	US20040265887 predicting a clinical response to treatment with a chemotherapeutic agent by determining the activity of a gene encoding a DNA repair enzyme
12/30/2004	US20040265882 Diabetes gene
12/30/2004	US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells
12/30/2004	US20040265866 Receptor on the surface of activated T-cells: ACT-4
12/30/2004	US20040265857 Cloning gene or fragment thereof via hybridization probe; solid phase synthesis; plasmids; for treating mycosis
12/30/2004	US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy

1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 3163